Literature DB >> 10356358

Cell adhesion properties and effects on receptor-mediated insulin endocytosis are independent properties of pp120, a substrate of the insulin receptor tyrosine kinase.

P Soni1, K A Al-Hosaini, M A Fernström, S M Najjar.   

Abstract

pp120 undergoes phosphorylation by the tyrosine kinase of the insulin, not the insulin-like growth factor 1 (IGF-1), receptor. Moreover, pp120 stimulates receptor-mediated insulin, but not IGF-1, endocytosis, suggesting that pp120 phosphorylation underlies its effect on insulin endocytosis. pp120 phosphorylation also underlies its bile acid transport and tumor suppression functions. In addition to depending on the intracellular tail, the cell adhesion property of pp120 depends on Arg98 in the N-terminal IgV-like ectoplasmic domain. To investigate whether this domain mediates the effect of pp120 on insulin endocytosis, we mutated Arg98 to Ala and examined whether this mutation altered pp120 phosphorylation and its effect on ligand endocytosis in transfected NIH 3T3 cells. This mutation did not modify either pp120 phosphorylation or its effect on receptor-mediated ligand endocytosis. These findings support the hypothesis that stimulation of insulin endocytosis by pp120 is not mediated by Arg98 in the N-terminal IgV-like ectoplasmic domain of pp120.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10356358     DOI: 10.1006/mcbr.1999.0116

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  3 in total

Review 1.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  The CEACAM1 expression is decreased in the liver of severely obese patients with or without diabetes.

Authors:  Wonae Lee
Journal:  Diagn Pathol       Date:  2011-05-11       Impact factor: 2.644

Review 3.  CEACAMs: their role in physiology and pathophysiology.

Authors:  Katharina Kuespert; Stefan Pils; Christof R Hauck
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.